메뉴 건너뛰기




Volumn 15, Issue 4, 2004, Pages 275-286

PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma

Author keywords

Autocrine tumor growth; Glivec; Platelet derived growth factor; Tumor angiogenesis; Tumor stroma

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; EPOTHILONE DERIVATIVE; FLUOROURACIL; IMATINIB; PACLITAXEL; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SEMAXANIB; VASCULOTROPIN ANTIBODY;

EID: 2942670180     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2004.03.002     Document Type: Article
Times cited : (286)

References (110)
  • 1
    • 0020533055 scopus 로고
    • Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor
    • Dolittle R.F., Hunkapiller M.W., Hood L.E., Devare S.G., Robbins K.C., Aaronson S.A., et al. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 221:1983;275-277
    • (1983) Science , vol.221 , pp. 275-277
    • Dolittle, R.F.1    Hunkapiller, M.W.2    Hood, L.E.3    Devare, S.G.4    Robbins, K.C.5    Aaronson, S.A.6
  • 4
    • 0021703127 scopus 로고
    • Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation
    • Gazit A., Igarashi H., Chiu I.-M., Srinivasan A., Yaniv A., Tronick S.R., et al. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell. 39:1984;89-97
    • (1984) Cell , vol.39 , pp. 89-97
    • Gazit, A.1    Igarashi, H.2    Chiu, I.-M.3    Srinivasan, A.4    Yaniv, A.5    Tronick, S.R.6
  • 5
    • 0021364016 scopus 로고
    • Human proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus
    • Josephs S.F., Guo C., Ratner L., Wong-Staal F. Human proto-oncogene nucleotide sequences corresponding to the transforming region of simian sarcoma virus. Science. 223:1984;487-491
    • (1984) Science , vol.223 , pp. 487-491
    • Josephs, S.F.1    Guo, C.2    Ratner, L.3    Wong-Staal, F.4
  • 6
    • 0023722311 scopus 로고
    • Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains
    • Beckmann M.P., Betsholtz C., Heldin C.-H., Westermark B., Di Marco E., Di Fiore P.P., et al. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 241:1988;1346-1349
    • (1988) Science , vol.241 , pp. 1346-1349
    • Beckmann, M.P.1    Betsholtz, C.2    Heldin, C.-H.3    Westermark, B.4    Di Marco, E.5    Di Fiore, P.P.6
  • 7
    • 0023916425 scopus 로고
    • Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in Rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects
    • Bywater M., Rorsman F., Bongcam-Rudloff E., Mark G., Hammacher A., Heldin C.-H., et al. Expression of recombinant platelet-derived growth factor A- and B-chain homodimers in Rat-1 cells and human fibroblasts reveals differences in protein processing and autocrine effects. Mol. Cell. Biol. 8:1988;2753-2762
    • (1988) Mol. Cell. Biol. , vol.8 , pp. 2753-2762
    • Bywater, M.1    Rorsman, F.2    Bongcam-Rudloff, E.3    Mark, G.4    Hammacher, A.5    Heldin, C.-H.6
  • 8
    • 0037434985 scopus 로고    scopus 로고
    • PDGF-D is a potent transforming and angiogenic growth factor
    • Li H., Fredriksson L., Li X., Eriksson U. PDGF-D is a potent transforming and angiogenic growth factor. Oncogene. 22:2003;1501-1510
    • (2003) Oncogene , vol.22 , pp. 1501-1510
    • Li, H.1    Fredriksson, L.2    Li, X.3    Eriksson, U.4
  • 9
    • 0037402488 scopus 로고    scopus 로고
    • Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment
    • Sirvent N., Maire G., Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 37:2003;1-19
    • (2003) Genes Chromosomes Cancer , vol.37 , pp. 1-19
    • Sirvent, N.1    Maire, G.2    Pedeutour, F.3
  • 10
    • 0031012850 scopus 로고    scopus 로고
    • Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma
    • Simon M.-P., Pedeutour F., Sirvent N., Grosgeorge J., Minoletti F., Coindre J.-M., et al. Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma. Nat. Genet. 15:1997;95-98
    • (1997) Nat. Genet. , vol.15 , pp. 95-98
    • Simon, M.-P.1    Pedeutour, F.2    Sirvent, N.3    Grosgeorge, J.4    Minoletti, F.5    Coindre, J.-M.6
  • 11
    • 0033178762 scopus 로고    scopus 로고
    • The dermatofibrosarcoma protuberans-associated collagen type Iα1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB
    • Shimizu A., O'Brien K.P., Sjöblom T., Pietras K., Buchdunger E., Collins V.P., et al. The dermatofibrosarcoma protuberans-associated collagen type Iα1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGF-BB. Cancer Res. 59:1999;3719-3723
    • (1999) Cancer Res. , vol.59 , pp. 3719-3723
    • Shimizu, A.1    O'Brien, K.P.2    Sjöblom, T.3    Pietras, K.4    Buchdunger, E.5    Collins, V.P.6
  • 12
    • 0035942502 scopus 로고    scopus 로고
    • Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans (DP)
    • Simon M.-P., Navarro M., Roux D., Pouysségur J. Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in dermatofibrosarcoma protuberans (DP). Oncogene. 20:2001;2965-2975
    • (2001) Oncogene , vol.20 , pp. 2965-2975
    • Simon, M.-P.1    Navarro, M.2    Roux, D.3    Pouysségur, J.4
  • 13
    • 0032505090 scopus 로고    scopus 로고
    • Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans
    • Greco A., Fusetti L., Villa R., Sozzi G., Minoletti F., Mauri P., et al. Transforming activity of the chimeric sequence formed by the fusion of collagen gene COL1A1 and the platelet derived growth factor b-chain gene in dermatofibrosarcoma protuberans. Oncogene. 17:1998;1313-1319
    • (1998) Oncogene , vol.17 , pp. 1313-1319
    • Greco, A.1    Fusetti, L.2    Villa, R.3    Sozzi, G.4    Minoletti, F.5    Mauri, P.6
  • 14
    • 0035421175 scopus 로고    scopus 로고
    • Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis
    • Sjöblom T., Shimizu A., O'Brien K.P., Pietras K., Dal Cin P., Buchdunger E., et al. Growth inhibition of dermatofibrosarcoma protuberans tumors by the platelet-derived growth factor receptor antagonist STI571 through induction of apoptosis. Cancer Res. 61:2001;5778-5783
    • (2001) Cancer Res. , vol.61 , pp. 5778-5783
    • Sjöblom, T.1    Shimizu, A.2    O'Brien, K.P.3    Pietras, K.4    Dal Cin, P.5    Buchdunger, E.6
  • 16
    • 0031947592 scopus 로고    scopus 로고
    • Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
    • Kindblom L.G., Remotti H.E., Aldenborg F., Meis-Kindblom J.M. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 152:1998;1259-1269
    • (1998) Am. J. Pathol. , vol.152 , pp. 1259-1269
    • Kindblom, L.G.1    Remotti, H.E.2    Aldenborg, F.3    Meis-Kindblom, J.M.4
  • 17
    • 0037087531 scopus 로고    scopus 로고
    • Inhibition of KIT tyrosine kinase activity: A novel molecular approach to the treatment of KIT-positive malignancies
    • Heinrich M.C., Blanke C.D., Druker B.J., Corless C.L. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J. Clin. Oncol. 20:2002;1692-1703
    • (2002) J. Clin. Oncol. , vol.20 , pp. 1692-1703
    • Heinrich, M.C.1    Blanke, C.D.2    Druker, B.J.3    Corless, C.L.4
  • 19
    • 0041971080 scopus 로고    scopus 로고
    • Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors
    • Hirota S., Ohashi A., Nishida T., Isozaki K., Kinoshita K., Shinomura Y., et al. Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors. Gastroenterology. 125:2003;660-667
    • (2003) Gastroenterology , vol.125 , pp. 660-667
    • Hirota, S.1    Ohashi, A.2    Nishida, T.3    Isozaki, K.4    Kinoshita, K.5    Shinomura, Y.6
  • 20
    • 0642368571 scopus 로고    scopus 로고
    • Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor
    • Heinrich M.C., Corless C.L., Demetri G.D., Blanke C.D., von Mehren M., Joensuu H., et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 21:2003;4342-4349
    • (2003) J. Clin. Oncol. , vol.21 , pp. 4342-4349
    • Heinrich, M.C.1    Corless, C.L.2    Demetri, G.D.3    Blanke, C.D.4    Von Mehren, M.5    Joensuu, H.6
  • 21
    • 0036045381 scopus 로고    scopus 로고
    • Tyrosine kinase fusion genes in chronic myeloproliferative diseases
    • Cross N.C., Reiter A. Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia. 16:2002;1207-1212
    • (2002) Leukemia , vol.16 , pp. 1207-1212
    • Cross, N.C.1    Reiter, A.2
  • 22
    • 0036202529 scopus 로고    scopus 로고
    • Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor beta
    • Steer E.J., Cross N.C. Myeloproliferative disorders with translocations of chromosome 5q31-35: role of the platelet-derived growth factor receptor beta. Acta Haematol. 107:2002;113-122
    • (2002) Acta Haematol. , vol.107 , pp. 113-122
    • Steer, E.J.1    Cross, N.C.2
  • 23
    • 0028224348 scopus 로고
    • Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
    • Golub T.R., Barker G.F., Lovett M., Gilliland D.G. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell. 77:1994;307-316
    • (1994) Cell , vol.77 , pp. 307-316
    • Golub, T.R.1    Barker, G.F.2    Lovett, M.3    Gilliland, D.G.4
  • 24
    • 0029966854 scopus 로고    scopus 로고
    • The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways
    • Carroll M., Tomasson M.H., Barker G.F., Golub T.R., Gilliland D.G. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. U.S.A. 93:1996;14845-14850
    • (1996) Proc. Natl. Acad. Sci. U.S.A. , vol.93 , pp. 14845-14850
    • Carroll, M.1    Tomasson, M.H.2    Barker, G.F.3    Golub, T.R.4    Gilliland, D.G.5
  • 25
    • 17144463437 scopus 로고    scopus 로고
    • A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein
    • Jousset C., Carron C., Boureux A., Quang C.T., Oury C., Dusanter-Fourt I., et al. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ oncoprotein. EMBO J. 16:1997;69-82
    • (1997) EMBO J. , vol.16 , pp. 69-82
    • Jousset, C.1    Carron, C.2    Boureux, A.3    Quang, C.T.4    Oury, C.5    Dusanter-Fourt, I.6
  • 26
    • 0033604460 scopus 로고    scopus 로고
    • Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein
    • Sjöblom T., Boureux A., Rönnstrand L., Heldin C.-H., Ghysdael J., Östman A. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein. Oncogene. 18:1999;7055-7062
    • (1999) Oncogene , vol.18 , pp. 7055-7062
    • Sjöblom, T.1    Boureux, A.2    Rönnstrand, L.3    Heldin, C.-H.4    Ghysdael, J.5    Östman, A.6
  • 27
    • 0033084227 scopus 로고    scopus 로고
    • TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
    • Tomasson M.H., Williams I.R., Hasserjian R., Udomsakdi C., McGrath S.M., Schwaller J., et al. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor. Blood. 93:1999;1707-1714
    • (1999) Blood , vol.93 , pp. 1707-1714
    • Tomasson, M.H.1    Williams, I.R.2    Hasserjian, R.3    Udomsakdi, C.4    McGrath, S.M.5    Schwaller, J.6
  • 28
    • 0033999917 scopus 로고    scopus 로고
    • Fatal myeloproliferation induced in mice by TEL/PDGFbetaR expression depends on PDGFbetaR tyrosines 579/581
    • Tomasson M.H., Sternberg D.W., Williams I.R., Carroll M., Cain D., Aster J.C., et al. Fatal myeloproliferation induced in mice by TEL/PDGFbetaR expression depends on PDGFbetaR tyrosines 579/581. J. Clin. Invest. 105:2000;423-432
    • (2000) J. Clin. Invest. , vol.105 , pp. 423-432
    • Tomasson, M.H.1    Sternberg, D.W.2    Williams, I.R.3    Carroll, M.4    Cain, D.5    Aster, J.C.6
  • 29
    • 0030669455 scopus 로고    scopus 로고
    • Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution
    • Abe A., Emi N., Tanimoto M., Terasaki H., Marunouchi T., Saito H. Fusion of the platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution. Blood. 90:1997;4271-4277
    • (1997) Blood , vol.90 , pp. 4271-4277
    • Abe, A.1    Emi, N.2    Tanimoto, M.3    Terasaki, H.4    Marunouchi, T.5    Saito, H.6
  • 30
    • 0035889128 scopus 로고    scopus 로고
    • Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia
    • Magnusson M.K., Meade K.E., Brown K.E., Arthur D.C., Krueger L.A., Barrett A.J., et al. Rabaptin-5 is a novel fusion partner to platelet-derived growth factor β receptor in chronic myelomonocytic leukemia. Blood. 98:2001;2518-2525
    • (2001) Blood , vol.98 , pp. 2518-2525
    • Magnusson, M.K.1    Meade, K.E.2    Brown, K.E.3    Arthur, D.C.4    Krueger, L.A.5    Barrett, A.J.6
  • 31
    • 18344404198 scopus 로고    scopus 로고
    • Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)
    • Kulkarni S., Heath C., Parker S., Chase A., Iqbal S., Pocock C.F., et al. Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21). Cancer Res. 60:2000;3592-3598
    • (2000) Cancer Res. , vol.60 , pp. 3592-3598
    • Kulkarni, S.1    Heath, C.2    Parker, S.3    Chase, A.4    Iqbal, S.5    Pocock, C.F.6
  • 32
    • 0031864246 scopus 로고    scopus 로고
    • Fusion of Huntington interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)
    • Ross T.S., Bernard O.A., Berger R., Gilliland D.G. Fusion of Huntington interacting protein 1 to platelet-derived growth factor beta receptor (PDGFbetaR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood. 91:1998;4419-4426
    • (1998) Blood , vol.91 , pp. 4419-4426
    • Ross, T.S.1    Bernard, O.A.2    Berger, R.3    Gilliland, D.G.4
  • 33
    • 0346186282 scopus 로고    scopus 로고
    • Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders
    • Baxter E.J., Kulkarni S., Vizmanos J.L., Jaju R., Martinelli G., Testoni N., et al. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders. Br. J. Haematol. 120:2003;251-256
    • (2003) Br. J. Haematol. , vol.120 , pp. 251-256
    • Baxter, E.J.1    Kulkarni, S.2    Vizmanos, J.L.3    Jaju, R.4    Martinelli, G.5    Testoni, N.6
  • 35
    • 0041335547 scopus 로고    scopus 로고
    • Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: A new clinical target for STI571/Glivec
    • Trempat P., Villalva C., Laurent G., Armstrong F., Delsol G., Dastugue N., et al. Chronic myeloproliferative disorders with rearrangement of the platelet-derived growth factor alpha receptor: a new clinical target for STI571/Glivec. Oncogene. 22:2003;5702-5706
    • (2003) Oncogene , vol.22 , pp. 5702-5706
    • Trempat, P.1    Villalva, C.2    Laurent, G.3    Armstrong, F.4    Delsol, G.5    Dastugue, N.6
  • 36
    • 1842474941 scopus 로고    scopus 로고
    • The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: Implications for diagnosis, classification, and management
    • doi: 10.1182/blood-2003-06-1824
    • Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DG, Coutre SE. The FIP1L1-PDGFR{alpha} fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2003. doi: 10.1182/blood-2003-06-1824
    • (2003) Blood
    • Gotlib, J.1    Cools, J.2    Malone, J.M.3    Schrier, S.L.4    Gilliland, D.G.5    Coutre, S.E.6
  • 37
    • 0344987881 scopus 로고    scopus 로고
    • A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    • Cools J., DeAngelo D.J., Gotlib J., Stover E.H., Legare R.D., Cortes J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N. Engl. J. Med. 348:2003;1201-1214
    • (2003) N. Engl. J. Med. , vol.348 , pp. 1201-1214
    • Cools, J.1    Deangelo, D.J.2    Gotlib, J.3    Stover, E.H.4    Legare, R.D.5    Cortes, J.6
  • 39
    • 10744228486 scopus 로고    scopus 로고
    • CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy
    • Pardanani A., Ketterling R.P., Brockman S.R., Flynn H.C., Paternoster S.F., Shearer B.M., et al. CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. Blood. 102:2003;3093-3096
    • (2003) Blood , vol.102 , pp. 3093-3096
    • Pardanani, A.1    Ketterling, R.P.2    Brockman, S.R.3    Flynn, H.C.4    Paternoster, S.F.5    Shearer, B.M.6
  • 40
    • 0038386031 scopus 로고    scopus 로고
    • Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
    • Pardanani A., Reeder T., Porrata L.F., Li C.Y., Tazelaar H.D., Baxter E.J., et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood. 101:2003;3391-3397
    • (2003) Blood , vol.101 , pp. 3391-3397
    • Pardanani, A.1    Reeder, T.2    Porrata, L.F.3    Li, C.Y.4    Tazelaar, H.D.5    Baxter, E.J.6
  • 41
    • 1642324059 scopus 로고    scopus 로고
    • The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA positive chronic eosinophilic leukemia
    • Cools J., Quentmeier H., Huntly B.J., Marynen P., Griffin J.D., Drexler H.G., et al. The EOL-1 cell line as an in vitro model for the study of FIP1L1-PDGFRA positive chronic eosinophilic leukemia. Blood. 103:2004;2802-2805
    • (2004) Blood , vol.103 , pp. 2802-2805
    • Cools, J.1    Quentmeier, H.2    Huntly, B.J.3    Marynen, P.4    Griffin, J.D.5    Drexler, H.G.6
  • 42
    • 0034659906 scopus 로고    scopus 로고
    • World Health Organization classification of tumors
    • Kleihues P., Sobin L.H. World Health Organization classification of tumors. Cancer. 88:2000;2887
    • (2000) Cancer , vol.88 , pp. 2887
    • Kleihues, P.1    Sobin, L.H.2
  • 44
    • 0026772431 scopus 로고
    • Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops
    • Hermanson M., Funa K., Hartman M., Claesson-Welsh L., Heldin C.-H., Westermark B., et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res. 52:1992;3213-3219
    • (1992) Cancer Res. , vol.52 , pp. 3213-3219
    • Hermanson, M.1    Funa, K.2    Hartman, M.3    Claesson-Welsh, L.4    Heldin, C.-H.5    Westermark, B.6
  • 45
    • 9044248587 scopus 로고    scopus 로고
    • Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas
    • Hermanson M., Funa K., Koopmann J., Maintz D., Waha A., Westermark B., et al. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor α receptor expression in human malignant gliomas. Cancer Res. 56:1996;164-171
    • (1996) Cancer Res. , vol.56 , pp. 164-171
    • Hermanson, M.1    Funa, K.2    Koopmann, J.3    Maintz, D.4    Waha, A.5    Westermark, B.6
  • 46
    • 0026793260 scopus 로고
    • Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors
    • Fleming T.P., Saxena A., Clark W.C., Robertson J.T., Oldfield E.H., Aaronson S.A., et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 52:1992;4550-4553
    • (1992) Cancer Res. , vol.52 , pp. 4550-4553
    • Fleming, T.P.1    Saxena, A.2    Clark, W.C.3    Robertson, J.T.4    Oldfield, E.H.5    Aaronson, S.A.6
  • 47
    • 0026600613 scopus 로고
    • Amplification of α-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin
    • Kumabe T., Sohma Y., Kayama T., Yoshimoto T., Yamamoto T. Amplification of α-platelet-derived growth factor receptor gene lacking an exon coding for a portion of the extracellular region in a primary brain tumor of glial origin. Oncogene. 7:1992;627-633
    • (1992) Oncogene , vol.7 , pp. 627-633
    • Kumabe, T.1    Sohma, Y.2    Kayama, T.3    Yoshimoto, T.4    Yamamoto, T.5
  • 48
    • 0037421971 scopus 로고    scopus 로고
    • A human brain tumor-derived PDGFR-alpha deletion mutant is transforming
    • Clarke I.D., Dirks P.B. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene. 22:2003;722-733
    • (2003) Oncogene , vol.22 , pp. 722-733
    • Clarke, I.D.1    Dirks, P.B.2
  • 49
    • 0001288041 scopus 로고
    • The biology of primate retrovirus
    • Klein G. (Ed.), New York: Raven;
    • Deinhardt F. The biology of primate retrovirus. In: Klein G. (Ed.), Viral oncology. New York: Raven; 1980. p. 359-398.
    • (1980) Viral Oncology , pp. 359-398
    • Deinhardt, F.1
  • 50
    • 0032401819 scopus 로고    scopus 로고
    • Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus
    • Uhrbom L., Hesselager G., Nistér M., Westermark B. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res. 58:1998;5275-5279
    • (1998) Cancer Res. , vol.58 , pp. 5275-5279
    • Uhrbom, L.1    Hesselager, G.2    Nistér, M.3    Westermark, B.4
  • 51
    • 0035425048 scopus 로고    scopus 로고
    • PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo
    • Dai C., Celestino J.C., Okada Y., Louis D.N., Fuller G.N., Holland E.C. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev. 15:2001;1913-1925
    • (2001) Genes Dev. , vol.15 , pp. 1913-1925
    • Dai, C.1    Celestino, J.C.2    Okada, Y.3    Louis, D.N.4    Fuller, G.N.5    Holland, E.C.6
  • 52
    • 0042591478 scopus 로고    scopus 로고
    • Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model
    • Hesselager G., Uhrbom L., Westermark B., Nister M. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res. 63:2003;4305-4309
    • (2003) Cancer Res. , vol.63 , pp. 4305-4309
    • Hesselager, G.1    Uhrbom, L.2    Westermark, B.3    Nister, M.4
  • 53
    • 0027361809 scopus 로고
    • Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells
    • Shamah S.M., Stiles C.D., Guha A. Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol. Cell. Biol. 13:1993;7203-7212
    • (1993) Mol. Cell. Biol. , vol.13 , pp. 7203-7212
    • Shamah, S.M.1    Stiles, C.D.2    Guha, A.3
  • 54
    • 0027980975 scopus 로고
    • Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor
    • Strawn L.M., Mann E., Elliger S.S., Chu L.M., Germain L.L., Niederfellner G., et al. Inhibition of glioma cell growth by a truncated platelet-derived growth factor-b receptor. J. Biol. Chem. 269:1994;21215-21222
    • (1994) J. Biol. Chem. , vol.269 , pp. 21215-21222
    • Strawn, L.M.1    Mann, E.2    Elliger, S.S.3    Chu, L.M.4    Germain, L.L.5    Niederfellner, G.6
  • 55
    • 0034665138 scopus 로고    scopus 로고
    • Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class
    • Kilic T., Alberta J.A., Zdunek P.R., Acar M., Iannarelli P., O'Reilly T., et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res. 60:2000;5143-5150
    • (2000) Cancer Res. , vol.60 , pp. 5143-5150
    • Kilic, T.1    Alberta, J.A.2    Zdunek, P.R.3    Acar, M.4    Iannarelli, P.5    O'Reilly, T.6
  • 56
    • 0024523834 scopus 로고
    • Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene
    • Pech M., Gazit A., Arnstein P., Aaronson S.A. Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene. Proc. Natl. Acad. Sci. U.S.A. 86:1989;2693-2697
    • (1989) Proc. Natl. Acad. Sci. U.S.A. , vol.86 , pp. 2693-2697
    • Pech, M.1    Gazit, A.2    Arnstein, P.3    Aaronson, S.A.4
  • 57
    • 0026581358 scopus 로고
    • Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin
    • Smits A., Funa K., Vassbotn F.S., Beausang-Linder M., af Ekenstam F., Heldin C.-H., et al. Expression of platelet-derived growth factor and its receptors in proliferative disorders of fibroblastic origin. Am. J. Pathol. 140:1992;639-648
    • (1992) Am. J. Pathol. , vol.140 , pp. 639-648
    • Smits, A.1    Funa, K.2    Vassbotn, F.S.3    Beausang-Linder, M.4    Af Ekenstam, F.5    Heldin, C.-H.6
  • 58
    • 0028012103 scopus 로고
    • Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: An immunohistochemical and in situ hybridization study
    • Wang J., Coltrera M.D., Gown A.M. Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Cancer Res. 54:1994;560-564
    • (1994) Cancer Res. , vol.54 , pp. 560-564
    • Wang, J.1    Coltrera, M.D.2    Gown, A.M.3
  • 59
    • 0030699247 scopus 로고    scopus 로고
    • The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
    • Lee S.B., Kolquist K.A., Nichols K., Englert C., Maheswaran S., Ladanyi M., et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat. Genet. 17:1997;309-313
    • (1997) Nat. Genet. , vol.17 , pp. 309-313
    • Lee, S.B.1    Kolquist, K.A.2    Nichols, K.3    Englert, C.4    Maheswaran, S.5    Ladanyi, M.6
  • 60
    • 0035242001 scopus 로고    scopus 로고
    • PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors
    • Zwerner J.P., May W.A. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors. Oncogene. 20:2001;626-633
    • (2001) Oncogene , vol.20 , pp. 626-633
    • Zwerner, J.P.1    May, W.A.2
  • 61
    • 0037198637 scopus 로고    scopus 로고
    • Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines
    • Zwerner J.P., May W.A. Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines. Oncogene. 21:2002;3847-3854
    • (2002) Oncogene , vol.21 , pp. 3847-3854
    • Zwerner, J.P.1    May, W.A.2
  • 62
    • 0032875460 scopus 로고    scopus 로고
    • Mechanism of action and in vivo role of platelet-derived growth factor
    • Heldin C.-H., Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol. Rev. 79:1999;1283-1316
    • (1999) Physiol. Rev. , vol.79 , pp. 1283-1316
    • Heldin, C.-H.1    Westermark, B.2
  • 65
    • 0036793520 scopus 로고    scopus 로고
    • Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ Receptors
    • Cao R., Bråkenhielm E., Li X., Pietras K., Widenfalk J., Östman A., et al. Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-αα and -αβ receptors. FASEB J. 16:2002;1575-1583
    • (2002) FASEB J. , vol.16 , pp. 1575-1583
    • Cao, R.1    Bråkenhielm, E.2    Li, X.3    Pietras, K.4    Widenfalk, J.5    Östman, A.6
  • 67
    • 0028557063 scopus 로고
    • Three isoforms of platelet-derived growth factors all have the capability to induce angiogenesis in vivo
    • Oikawa T., Onozawa C., Sakaguchi M., Morita I., Murota S. Three isoforms of platelet-derived growth factors all have the capability to induce angiogenesis in vivo. Biol. Pharm. Bull. 17:1994;1686-1688
    • (1994) Biol. Pharm. Bull. , vol.17 , pp. 1686-1688
    • Oikawa, T.1    Onozawa, C.2    Sakaguchi, M.3    Morita, I.4    Murota, S.5
  • 68
    • 10744227995 scopus 로고    scopus 로고
    • Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases
    • Uehara H., Kim S.J., Karashima T., Shepherd D.L., Fan D., Tsan R., et al. Effects of blocking platelet-derived growth factor-receptor signaling in a mouse model of experimental prostate cancer bone metastases. J. Natl. Cancer Inst. 95:2003;458-470
    • (2003) J. Natl. Cancer Inst. , vol.95 , pp. 458-470
    • Uehara, H.1    Kim, S.J.2    Karashima, T.3    Shepherd, D.L.4    Fan, D.5    Tsan, R.6
  • 69
    • 0345798150 scopus 로고    scopus 로고
    • Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors
    • Abramsson A., Lindblom P., Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J. Clin. Invest. 112:2003;1142-1151
    • (2003) J. Clin. Invest. , vol.112 , pp. 1142-1151
    • Abramsson, A.1    Lindblom, P.2    Betsholtz, C.3
  • 70
    • 0346333243 scopus 로고    scopus 로고
    • Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model
    • Hwang R.F., Yokoi K., Bucana C.D., Tsan R., Killion J.J., Evans D.B., et al. Inhibition of platelet-derived growth factor receptor phosphorylation by STI571 (Gleevec) reduces growth and metastasis of human pancreatic carcinoma in an orthotopic nude mouse model. Clin. Cancer Res. 9:2003;6534-6544
    • (2003) Clin. Cancer Res. , vol.9 , pp. 6534-6544
    • Hwang, R.F.1    Yokoi, K.2    Bucana, C.D.3    Tsan, R.4    Killion, J.J.5    Evans, D.B.6
  • 71
    • 0038476608 scopus 로고    scopus 로고
    • Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors
    • Bergers G., Song S., Meyer-Morse N., Bergsland E., Hanahan D. Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J. Clin. Invest. 111:2003;1287-1295
    • (2003) J. Clin. Invest. , vol.111 , pp. 1287-1295
    • Bergers, G.1    Song, S.2    Meyer-Morse, N.3    Bergsland, E.4    Hanahan, D.5
  • 72
    • 0344837389 scopus 로고    scopus 로고
    • Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment
    • Guo P., Hu B., Gu W., Xu L., Wang D., Huang H.J., et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am. J. Pathol. 162:2003;1083-1093
    • (2003) Am. J. Pathol. , vol.162 , pp. 1083-1093
    • Guo, P.1    Hu, B.2    Gu, W.3    Xu, L.4    Wang, D.5    Huang, H.J.6
  • 73
    • 1442290142 scopus 로고    scopus 로고
    • Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms
    • Erber R., Thurnher A., Katsen A.D., Groth G., Kerger H., Hammes H.P., et al. Combined inhibition of VEGF- and PDGF-signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 18:2004;338-340
    • (2004) FASEB J. , vol.18 , pp. 338-340
    • Erber, R.1    Thurnher, A.2    Katsen, A.D.3    Groth, G.4    Kerger, H.5    Hammes, H.P.6
  • 74
    • 84862432400 scopus 로고    scopus 로고
    • PDGF production by B16 melanoma cells leads to increased pericyte coverage of vessels and an associated increase in tumor growth rate
    • in press.
    • Furuhashi M, Sjöblom T, Abramsson A., Ellingsen J, Micke P, Li H, et al. PDGF production by B16 melanoma cells leads to increased pericyte coverage of vessels and an associated increase in tumor growth rate. Cancer Res, in press.
    • Cancer Res
    • Furuhashi, M.1    Sjöblom, T.2    Abramsson, A.3    Ellingsen, J.4    Micke, P.5    Li, H.6
  • 77
    • 1042301958 scopus 로고    scopus 로고
    • Targeting the platelet-derived growth factor in antivascular therapy for human ovarian carcinoma
    • Apte S.M., Fan D., Killion J.J., Fidler I.J. Targeting the platelet-derived growth factor in antivascular therapy for human ovarian carcinoma. Clin. Cancer Res. 10:2004;807-908
    • (2004) Clin. Cancer Res. , vol.10 , pp. 807-908
    • Apte, S.M.1    Fan, D.2    Killion, J.J.3    Fidler, I.J.4
  • 78
    • 0027744498 scopus 로고
    • Microvascular pericytes express platelet-derived growth factor-β receptors in human healing wounds and colorectal adenocarcinoma
    • Sundberg C., Ljungström M., Lindmark G., Gerdin B., Rubin K. Microvascular pericytes express platelet-derived growth factor-β receptors in human healing wounds and colorectal adenocarcinoma. Am. J. Pathol. 143:1993;1377-1388
    • (1993) Am. J. Pathol. , vol.143 , pp. 1377-1388
    • Sundberg, C.1    Ljungström, M.2    Lindmark, G.3    Gerdin, B.4    Rubin, K.5
  • 79
    • 0037967272 scopus 로고    scopus 로고
    • Tumorigenesis and the angiogenic switch
    • Bergers G., Benjamin L.E. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer. 3:2003;401-410
    • (2003) Nat. Rev. Cancer , vol.3 , pp. 401-410
    • Bergers, G.1    Benjamin, L.E.2
  • 80
    • 0033617532 scopus 로고    scopus 로고
    • Effects of angiogenesis inhibitors on multistage carcinogenesis in mice
    • Bergers G., Javaherian K., Lo K.M., Folkman J., Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science. 284:1999;808-812
    • (1999) Science , vol.284 , pp. 808-812
    • Bergers, G.1    Javaherian, K.2    Lo, K.M.3    Folkman, J.4    Hanahan, D.5
  • 81
    • 0026439870 scopus 로고
    • Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas
    • Plate K.H., Breier G., Farrell C.L., Risau W. Platelet-derived growth factor receptor-β is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab. Invest. 67:1992;529-534
    • (1992) Lab. Invest. , vol.67 , pp. 529-534
    • Plate, K.H.1    Breier, G.2    Farrell, C.L.3    Risau, W.4
  • 82
    • 0008887031 scopus 로고
    • Endothelial cell hyperplasia in human glioblastoma: Coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation
    • Hermanson M., Nistér M., Betsholtz C., Heldin C.-H., Westermark B., Funa K. Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc. Natl. Acad. Sci. U.S.A. 85:1988;7748-7752
    • (1988) Proc. Natl. Acad. Sci. U.S.A. , vol.85 , pp. 7748-7752
    • Hermanson, M.1    Nistér, M.2    Betsholtz, C.3    Heldin, C.-H.4    Westermark, B.5    Funa, K.6
  • 84
    • 0029978211 scopus 로고    scopus 로고
    • Localization of platelet-derived growth factor β receptor expression in the periepithelial stroma of human breast carcinoma
    • Bhardwaj B., Klassen J., Cossette N., Sterns E., Tuck A., Deeley R., et al. Localization of platelet-derived growth factor β receptor expression in the periepithelial stroma of human breast carcinoma. Clin. Cancer Res. 2:1996;773-782
    • (1996) Clin. Cancer Res. , vol.2 , pp. 773-782
    • Bhardwaj, B.1    Klassen, J.2    Cossette, N.3    Sterns, E.4    Tuck, A.5    Deeley, R.6
  • 85
    • 0027723524 scopus 로고
    • Stromal expression of platelet-derived growth factor β-receptor and platelet-derived growth factor B-chain in colorectal cancer
    • Lindmark G., Sundberg C., Glimelius B., Påhlman L., Rubin K., Gerdin B. Stromal expression of platelet-derived growth factor β-receptor and platelet-derived growth factor B-chain in colorectal cancer. Lab. Invest. 69:1993;682-689
    • (1993) Lab. Invest. , vol.69 , pp. 682-689
    • Lindmark, G.1    Sundberg, C.2    Glimelius, B.3    Påhlman, L.4    Rubin, K.5    Gerdin, B.6
  • 86
    • 0030725954 scopus 로고    scopus 로고
    • Expression in lung carcinomas of platelet-derived growth factor and its receptors
    • Kawai T., Hiroi S., Torikata C. Expression in lung carcinomas of platelet-derived growth factor and its receptors. Lab. Invest. 77:1997;431-436
    • (1997) Lab. Invest. , vol.77 , pp. 431-436
    • Kawai, T.1    Hiroi, S.2    Torikata, C.3
  • 87
    • 0025019999 scopus 로고
    • Expression of platelet-derived growth factor β-receptors on stromal tissue cells in human carcinoid tumors
    • Funa K., Papanicolaou V., Juhlin C., Rastad J., Åkerström G., Heldin C.H., et al. Expression of platelet-derived growth factor β-receptors on stromal tissue cells in human carcinoid tumors. Cancer Res. 50:1990;748-753
    • (1990) Cancer Res. , vol.50 , pp. 748-753
    • Funa, K.1    Papanicolaou, V.2    Juhlin, C.3    Rastad, J.4    Åkerström, G.5    Heldin, C.H.6
  • 88
    • 0029146793 scopus 로고
    • Induction of platelet-derived growth factor a and B chains and over-expression of their receptors in human pancreatic cancer
    • Ebert M., Yokoyama M., Friess H., Kobrin M.S., Büchler M.W., Korc M. Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer. 62:1995;529-535
    • (1995) Int. J. Cancer , vol.62 , pp. 529-535
    • Ebert, M.1    Yokoyama, M.2    Friess, H.3    Kobrin, M.S.4    Büchler, M.W.5    Korc, M.6
  • 89
    • 0037389850 scopus 로고    scopus 로고
    • Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors
    • Fjällskog M.L., Lejonklou M.H., Öberg K.E., Eriksson B.K., Janson E.T. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. Clin. Cancer Res. 9:2003;1469-1473
    • (2003) Clin. Cancer Res. , vol.9 , pp. 1469-1473
    • Fjällskog, M.L.1    Lejonklou, M.H.2    Öberg, K.E.3    Eriksson, B.K.4    Janson, E.T.5
  • 90
    • 0027397240 scopus 로고
    • Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB
    • Forsberg K., Valyi-Nagy I., Heldin C.-H., Herlyn M., Westermark B. Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. Natl. Acad. Sci. U.S.A. 90:1993;393-397
    • (1993) Proc. Natl. Acad. Sci. U.S.A. , vol.90 , pp. 393-397
    • Forsberg, K.1    Valyi-Nagy, I.2    Heldin, C.-H.3    Herlyn, M.4    Westermark, B.5
  • 91
    • 0032477806 scopus 로고    scopus 로고
    • Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
    • Skobe M., Fusenig N.E. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation. Proc. Natl. Acad. Sci. U.S.A. 95:1998;1050-1055
    • (1998) Proc. Natl. Acad. Sci. U.S.A. , vol.95 , pp. 1050-1055
    • Skobe, M.1    Fusenig, N.E.2
  • 92
    • 0034618408 scopus 로고    scopus 로고
    • Human breast carcinoma desmoplasia is PDGF initiated
    • Shao Z.M., Nguyen M., Barsky S.H. Human breast carcinoma desmoplasia is PDGF initiated. Oncogene. 19:2000;4337-4345
    • (2000) Oncogene , vol.19 , pp. 4337-4345
    • Shao, Z.M.1    Nguyen, M.2    Barsky, S.H.3
  • 93
    • 0035291243 scopus 로고    scopus 로고
    • Delivery of molecular and cellular medicine to solid tumors
    • Jain R.K. Delivery of molecular and cellular medicine to solid tumors. Adv. Drug Deliv. Rev. 46:2001;149-168
    • (2001) Adv. Drug Deliv. Rev. , vol.46 , pp. 149-168
    • Jain, R.K.1
  • 94
    • 0035297541 scopus 로고    scopus 로고
    • Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors
    • Pietras K., Östman A., Sjöquist M., Buchdunger E., Reed R.K., Heldin C.H., et al. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Cancer Res. 61:2001;2929-2934
    • (2001) Cancer Res. , vol.61 , pp. 2929-2934
    • Pietras, K.1    Östman, A.2    Sjöquist, M.3    Buchdunger, E.4    Reed, R.K.5    Heldin, C.H.6
  • 95
    • 0036790060 scopus 로고    scopus 로고
    • Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy
    • Pietras K., Rubin K., Sjöblom T., Buchdunger E., Sjöquist M., Heldin C.-H., et al. Inhibition of PDGF receptor signaling in tumor stroma enhances antitumor effect of chemotherapy. Cancer Res. 62:2002;5476-5484
    • (2002) Cancer Res. , vol.62 , pp. 5476-5484
    • Pietras, K.1    Rubin, K.2    Sjöblom, T.3    Buchdunger, E.4    Sjöquist, M.5    Heldin, C.-H.6
  • 96
    • 0141567995 scopus 로고    scopus 로고
    • STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake
    • Pietras K., Stumm M., Hubert M., Buchdunger E., Rubin K., Heldin C.-H., et al. STI571 enhances the therapeutic index of epothilone B by a tumor-selective increase of drug uptake. Clin. Cancer Res. 9:2003;3779-3787
    • (2003) Clin. Cancer Res. , vol.9 , pp. 3779-3787
    • Pietras, K.1    Stumm, M.2    Hubert, M.3    Buchdunger, E.4    Rubin, K.5    Heldin, C.-H.6
  • 97
    • 0037143794 scopus 로고    scopus 로고
    • Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans
    • Maki R.G., Awan R.A., Dixon R.H., Jhanwar S., Antonescu C.R. Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Int. J. Cancer. 100:2002;623-626
    • (2002) Int. J. Cancer , vol.100 , pp. 623-626
    • Maki, R.G.1    Awan, R.A.2    Dixon, R.H.3    Jhanwar, S.4    Antonescu, C.R.5
  • 98
    • 0036727124 scopus 로고    scopus 로고
    • Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans
    • Rubin B.P., Schuetze S.M., Eary J.F., Norwood T.H., Mirza S., Conrad E.U., et al. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans. J. Clin. Oncol. 20:2002;3586-3591
    • (2002) J. Clin. Oncol. , vol.20 , pp. 3586-3591
    • Rubin, B.P.1    Schuetze, S.M.2    Eary, J.F.3    Norwood, T.H.4    Mirza, S.5    Conrad, E.U.6
  • 99
    • 0038388677 scopus 로고    scopus 로고
    • Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: A new case report
    • Pitini V., Arrigo C., Teti D., Barresi G., Righi M., Alo G. Response to STI571 in chronic myelomonocytic leukemia with platelet derived growth factor beta receptor involvement: a new case report. Haematologica. 88:2003;ECR18
    • (2003) Haematologica , vol.88 , pp. 18
    • Pitini, V.1    Arrigo, C.2    Teti, D.3    Barresi, G.4    Righi, M.5    Alo, G.6
  • 100
    • 0141816686 scopus 로고    scopus 로고
    • Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta
    • Garcia J.L., Font de Mora J., Hernandez J.M., Queizan J.A., Gutierrez N.C., San Miguel J.F. Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta. Blood. 102:2003;2699-2700
    • (2003) Blood , vol.102 , pp. 2699-2700
    • Garcia, J.L.1    Font De Mora, J.2    Hernandez, J.M.3    Queizan, J.A.4    Gutierrez, N.C.5    San Miguel, J.F.6
  • 101
    • 0037103624 scopus 로고    scopus 로고
    • Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta
    • Apperley J.F., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J., Baxter E.J. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N. Engl. J. Med. 347:2002;481-487
    • (2002) N. Engl. J. Med. , vol.347 , pp. 481-487
    • Apperley, J.F.1    Gardembas, M.2    Melo, J.V.3    Russell-Jones, R.4    Bain, B.J.5    Baxter, E.J.6
  • 102
    • 0036682958 scopus 로고    scopus 로고
    • Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β receptor fusion oncogene
    • Magnusson M.K., Meade K.E., Nakamura R., Barrett J., Dunbar C.E. Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor β receptor fusion oncogene. Blood. 100:2002;1088-1091
    • (2002) Blood , vol.100 , pp. 1088-1091
    • Magnusson, M.K.1    Meade, K.E.2    Nakamura, R.3    Barrett, J.4    Dunbar, C.E.5
  • 103
    • 0942276859 scopus 로고    scopus 로고
    • Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome
    • Klion A.D., Robyn J., Akin C., Noel P., Brown M., Law M., et al. Molecular remission and reversal of myelofibrosis in response to imatinib mesylate treatment in patients with the myeloproliferative variant of hypereosinophilic syndrome. Blood. 103:2004;473-478
    • (2004) Blood , vol.103 , pp. 473-478
    • Klion, A.D.1    Robyn, J.2    Akin, C.3    Noel, P.4    Brown, M.5    Law, M.6
  • 104
    • 0345688603 scopus 로고    scopus 로고
    • Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias
    • Shah N.P., Sawyers C.L. Mechanisms of resistance to STI571 in Philadelphia chromosome-associated leukemias. Oncogene. 22:2003;7389-7395
    • (2003) Oncogene , vol.22 , pp. 7389-7395
    • Shah, N.P.1    Sawyers, C.L.2
  • 105
    • 0142119964 scopus 로고    scopus 로고
    • PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease
    • Cools J., Stover E.H., Boulton C.L., Gotlib J., Legare R.D., Amaral S.M., et al. PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRalpha-induced myeloproliferative disease. Cancer Cell. 3:2003;459-469
    • (2003) Cancer Cell , vol.3 , pp. 459-469
    • Cools, J.1    Stover, E.H.2    Boulton, C.L.3    Gotlib, J.4    Legare, R.D.5    Amaral, S.M.6
  • 106
    • 0033613119 scopus 로고    scopus 로고
    • Platelet-derived growth factor b receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling
    • Heuchel R., Berg A., Tallquist M., Åhlén K., Reed R.K., Rubin K., et al. Platelet-derived growth factor b receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11410-11415
    • (1999) Proc. Natl. Acad. Sci. U.S.A. , vol.96 , pp. 11410-11415
    • Heuchel, R.1    Berg, A.2    Tallquist, M.3    Åhlén, K.4    Reed, R.K.5    Rubin, K.6
  • 107
    • 1042301962 scopus 로고    scopus 로고
    • Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma
    • Tamborini E., Bonadiman L., Greco A., Gronchi A., Riva C., Bertulli R., et al. Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma. Clin. Cancer Res. 10:2004;938-943
    • (2004) Clin. Cancer Res. , vol.10 , pp. 938-943
    • Tamborini, E.1    Bonadiman, L.2    Greco, A.3    Gronchi, A.4    Riva, C.5    Bertulli, R.6
  • 108
    • 0842311601 scopus 로고    scopus 로고
    • Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and akt inactivation
    • Matei D., Chang D.D., Jeng M.-H. Imatinib mesylate (Gleevec) inhibits ovarian cancer cell growth through a mechanism dependent on platelet-derived growth factor receptor alpha and akt inactivation. Clin. Cancer Res. 10:2004;681-690
    • (2004) Clin. Cancer Res. , vol.10 , pp. 681-690
    • Matei, D.1    Chang, D.D.2    Jeng, M.-H.3
  • 109
    • 1642336256 scopus 로고    scopus 로고
    • A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression
    • Ustach C.V., Taube M.E., Hurst N.J. Jr., Bhagat S., Bonfil R.D., Cher M.L., et al. A potential oncogenic activity of platelet-derived growth factor D in prostate cancer progression. Cancer Res. 64:2004;1722-1729
    • (2004) Cancer Res. , vol.64 , pp. 1722-1729
    • Ustach, C.V.1    Taube, M.E.2    Hurst Jr., N.J.3    Bhagat, S.4    Bonfil, R.D.5    Cher, M.L.6
  • 110
    • 0842323936 scopus 로고    scopus 로고
    • Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
    • Beppu K., Jaboine J., Merchant M.S., Mackall C.L., Thiele C.J. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J. Natl. Cancer Inst. 96:2004;46-55
    • (2004) J. Natl. Cancer Inst. , vol.96 , pp. 46-55
    • Beppu, K.1    Jaboine, J.2    Merchant, M.S.3    MacKall, C.L.4    Thiele, C.J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.